SCHEMBL24377091

SCHEMBL24377091

c1ccc(-c2ccc3c(-c4ccc5cc(-c6nc(-c7ccc8ccccc8c7)nc(-c7ccc8ccccc8c7)n6)ccc5c4)cccc3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 4/20 0.45
HSD17B2 P37059 4/20 0.45
ESR1 P03372 5/20 0.43
ESR2 Q92731 5/20 0.43
GSTP1 P09211 1/20 0.43
CYP1A2 P05177 2/20 0.43
KDM4E B2RXH2 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
TP53 P04637 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
CYP17A1 P05093 1/20 0.42
CYP19A1 P11511 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA1 P30542 1/20 0.42
CA12 O43570 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25680783 0.97 ALDH1A1 (0.44) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24377056 0.97 HSD17B1 (0.48) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL21667499 0.95 ALDH1A1 (0.45) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL25680758 0.95 HSD17B1 (0.43) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL17655851 0.95 HSD17B1 (0.47) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24377388 0.95 HSD17B1 (0.49) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL24377068 0.95 HSD17B1 (0.49) HSD17B1HSD17B2ESR1ESR2CYP1A2
SCHEMBL18965462 0.94 ALDH1A1 (0.46) HSD17B1HSD17B2ESR1ESR2GSTP1
SCHEMBL27252843 0.94 ALDH1A1 (0.46) HSD17B1HSD17B2GSTP1CYP1A2KDM4E
SCHEMBL24770249 0.93 CA12 (0.48) HSD17B1HSD17B2ESR1ESR2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2022-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220131082-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, OR51E2, ETV6 HSD17B1 3492/4885HSD17B2 2954/4885ESR1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.